Cambio - Excellence in Molecular Biology

In vitro Transcription

In vitro Transcription: mRNA Quality Control

Benchtop PAGE mRNA QC is the New LC/MS

Tired of wait times and costs associated with outsourcing your mRNA for liquid chromatography/mass spectrometry (LC/MS) 5’ capping efficiency and 3’ tail length analyses? Now you can easily perform precise quantitative mRNA 5’ capping efficiency and 3’ poly(A) tail length assessments using standard lab equipment with the EZ-QC™ mRNA Assay Kits.

Discover quantitative fluorescence-based benchtop polyacrylamide gel electrophoresis (PAGE) assays for accurate and cost-effective QC of mRNA 5’ capping and 3’ poly(A) tail length analysis in a single day. Accelerate your mRNA research with the EZ-QC™ Kits for a fraction of the cost of LC/MS.

Benefits:

  • Fast benchtop 5’ capping and 3’ tailing QC analyses
  • Low-input mRNA (picomoles, not micromoles!)
  • Uses common polyacrylamide gel electrophoresis (PAGE) equipment
  • Cost-effective – stretch your budget for more experiments

 

How Our EZ-QC™ mRNA Assays Work

 

EZ-QC™ mRNA Capping Efficiency Assay Kit
Quantitates total capping efficiency (% capped vs uncapped RNA) of synthesized mRNA

How it works:

 

  • A chimeric RNA-DNA-RNA Targeting Oligonucleotide (user provided) hybridizes to the 5′ end of synthesized mRNA.
  • The hybridization complex undergoes RNase H cleavage, releasing capped and uncapped 5′-end fragments.
  • Released capped and uncapped 5′-end fragments are resolved using PAGE and quantitated by fluorescence-based gel band analysis.

 

EZ-QC™ mRNA Cap 1 Efficiency Assay Kit
Quantitates the percentage of Cap 1 vs Cap 0 caps of synthesized mRNA

How it works:

  • 5’ ends of a synthesized mRNA sample are labeled fluorescently with cyanine5 hydrazide (Cy5).
  • Hydrolysis of the Cy5-labeled mRNA mixture releases Cy5-labeled Cap 1 and Cap 0 caps.
  • Size resolution by PAGE and fluorescence-based gel imaging is used to determine percentage of Cap 1 vs
    Cap 0.

 

 

EZ-QC™ mRNA Poly(A) Tail Length Assay Kit
Quantitates poly(A) tail length of synthesized mRNA

How it works:

  • RNase A is used to digest the synthesized mRNA, leaving only intact Poly(A) tails.
  • Poly(A) tails are stained with fluorescent dyes (e.g., SYBR Gold Nucleic Acid Gel Stain (Invitrogen) + provided poly(A) fluorescence enhancer).
  • Poly(A) tail lengths (from 20 to >300 A’s) are resolved using PAGE with our proprietary Poly(A) 20-mer Ladder and quantitated by fluorescence-based gel band analysis.

 

EZ-QC™ XBG mRNA Capping Efficiency Assay Kit

EZ-QC™ XBG mRNA Capping Efficiency Assay Kit

CellScript

Catalogue No.DescriptionPack SizePriceQty
XBG250310EZ-QC™ XBG mRNA Capping Efficiency Assay Kit10 rxns £320.00 Quantity Add to Order

Description

The EZ-QC™ XBG mRNA Capping Efficiency Assay Kit provides quantitative capping efficiency (percent capped RNA content) analysis of synthesized mRNA containing a Xenopus beta-globin (XBG) 5' UTR (untranslated region). Since only capped RNAs are expressed in cells, it is essential to have the highest possible percentage of capped RNAs present in a sample. The EZ-QC™ XBG mRNA Capping Efficiency Assay Kit simplifies analysis and replaces tedious and expensive capping efficiency determination methods such as HPLC and mass spectrometry, instead allowing for determination based upon standard polyacrylamide gel electrophoresis (PAGE) methodology.

The EZ-QC™ XBG mRNA Capping Efficiency Assay utilizes a chimeric RNA-DNA-RNA Targeting Oligonucleotide (kit provided) which hybridizes to the 5'-end region of an RNA mixture when the mRNA construct contains a Xenopus beta-globin 5' UTR. This hybridization complex serves as a substrate for RNase H cleavage releasing the capped and uncapped 5'-end fragments which can subsequently be resolved via PAGE and quantified by gel band analysis. The method allows for straightforward, fluorescence-based calculation of the percent capped RNA content of the sample. The specificity of the Targeting Oligonucleotide, designed to facilitate cutting the mRNA at a precise location, provides greater confidence in determining the percentage of capped/uncapped content of the assayed RNA sample.

Note: The EZ-QC™ XBG mRNA Capping Efficiency Assay does not differentiate between Cap 0 and Cap 1 capped RNAs, only between capped (Cap 0 Cap 1) and uncapped RNAs.

Alternatively, the EZ-QC™ mRNA Capping Efficiency Assay Kit is also designed for determination of percentage capped RNA content but requires the end user to provide their own chimeric RNA-DNA-RNA Targeting Oligonucleotide. For determination of Cap 0 vs Cap 1 content, CELLSCRIPT™ also offers the EZ-QC™ mRNA Cap 1 Efficiency Assay Kit as well as the EZ-QC™ mRNA Poly(A) Tail Length Assay Kit for complete mRNA characterization. For more information about the EZ-QC™ mRNA quality control technologies, visit our mRNA QC analysis hub.

 

Resolution of capped and uncapped 5’-end fragments
Mixtures of capped and uncapped mRNA were assayed using the EZ-QC™ XBG mRNA Capping Efficiency Assay Kit and resolved on a polyacrylamide gel (Figure 1A). The Targeting Oligonucleotide facilitates cutting the mRNA at a single, repeatable location allowing for greater confidence in determining the percentage of capped and uncapped content of the assayed samples. The percent capped and uncapped mRNA in a mixture are calculated with a simple readout from any gel imaging system (Figure 1B).
 
RM-Capping Efficiency XBG_Example Data fig1A
Figure 1A. Capped and uncapped 5’-end fragments are efficiently resolved by PAGE allowing for capping efficiency analysis with standard lab equipment.
 

 

Figure 1B. Densitometric data from lanes 4, 5, and 6 from the above PAGE gel using a Syngene® G:Box Gel Documentation System. The percent capped and uncapped mRNA in each mixture are calculated using a simple readout.

 

Materials Supplied:

Important Store at -20°C in a freezer without a defrost cycle. Do not store at –70°C.

 

 

Materials Required, but not Supplied

Terms & Conditions: The Product listed is currently offered by CELLSCRIPT™ for research use only under the defined Terms and Conditions.

 

Troubleshooting Guide:

 

 

Symptom Solution
More than two bands present in the capped/uncapped region of the gel The Targeting Oligo hybridized in multiple locations.

 

  • Run the capped and uncapped experimental samples alongside a kit control reaction to identify the experimental bands of interest, then quantitate only the bands of interest.

Note: the released 5'-end fragments from the experimental mRNAs may not comigrate with those of the control reaction depending on the sequence of the experimental mRNAs.

Targeting Oligo migrates within the capped/uncapped excised fragment range.

 

  • Run the capped and uncapped experimental samples alongside a lane containing the XBG 5' UTR Targeting Oligo-only to identify the experimental bands of interest, then quantitate only the bands of interest.
Faint capped/uncapped bands mRNA 5'-end secondary structure is preventing efficient hybridization of the Targeting Oligo.

 

  • Preanneal the mRNA and Targeting Oligo, via mixing, heating and cooling, before adding the rest of the reaction components.
A molar excess of Targeting Oligo was not used in the reaction. Unhybridized Targeting Oligo should be visible on the gel.

 

  • Recheck experimental stoichiometry.
  • Add more Targeting Oligo to the reaction.
Load more completed reaction sample per well.
Increase the reaction incubation time to 60 minutes.
Near full lane of many bands RNase contamination.

 

XBG 5' UTR Targeting Oligo is degrading.

 

  • Run a sample of the XBG 5' UTR Targeting Oligo-only on a gel to assay for integrity.
Fuzzy bands Problems with the PAGE system (e.g., gel not totally polymerized, gel ran too hot, urea wasn't blown out of the wells just prior to sample loading, buffer issue).

 

  • Rerun the gel.
Capped and uncapped bands unresolved A <20% polyacrylamide gel was used.

 

  • Rerun the gel using 20% polyacrylamide. Commercially-available pre-poured 15% gels most often do not resolve the bands adequately.

 

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200

Protocols

Manual

SDS

These are both links to the manufacturer's page

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200

Applications & Benefits

  • Quantitate mRNA 5’ capping efficiency of Xenopus beta-globin (XBG) 5’ UTR-containing mRNA using standard polyacrylamide gel electrophoresis (PAGE).
  • Kit provides all assay components needed, including an XBG 5’ UTR Targeting Oligonucleotide and XBG 5’ UTR Control Mix.
  • Generate same-day percent capped RNA quality control results in your lab.
  • Experience cost-savings through use of common laboratory equipment, rather than specialized instrumentation.
  • Research use only

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200

Related products

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200